Abstract:disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that lowering of low-density lipoprotein (LDL) cholesterol is related to a reduction in CHD risk. The reduction of serum cholesterol levels has mainly been accomplished by inhibiting cholesterol biosynthesis or by blocking the absorption of dietary cholesterol. Statins, such as pravastatin, that effectively inhibit cholesterol biosynthesis are HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase) inhibitors and are widely prescribed in the treatment of hypercholesterolemia. Several squalene synthesis inhibitors have been also reported. SCH-48461 (a trans-azetidinone) and 4 ,6 -bis((2-fluorophenyl)carbamoyl) b-O-cellobioside (a steriodal glycoside) have recently been reported to be cholesterol absorption inhibitors. Phytosterols, or plant sterols, are an interesting class of compound due to their application and biological activities. The phytosterols found most frequently in nature are b-sitosterol, campesterol, and stigmasterol. It has been known that they inhibit the absorption of dietary and endogenously produced cholesterol from the small intestine, reducing blood cholesterol concentrations both in animal models and in humans. b-Sitosterol and b-sitostanol fatty acid esters were recently commercialized as food additives to reduce serum cholesterol levels. A novel hydrophilic phytostanol analogue, FM-VP4, was also developed to reduce serum cholesterol levels. However, even with the current therapeutic agents, it is not easy to achieve proper plasma cholesterol levels without side effect. Therefore the discovery of more effective, well-tolerated agents that reduce high cholesterol levels is needed. We here report the synthesis and interesting pharmacologic properties of novel succinamic acid ester derivatives that are bsitosterol analogues, compounds 1 and 2, that have the ability to lower plasma cholesterol levels and that can be more effective cholesterol-lowering alternatives to b-sitosterol and bsitostanol fatty acid esters. Chemistry The synthesis of b-sitosterol analogues 1 and 2 are summarized Chart 1. The b-sitosterol-3-hemisuccinate ester 1 was prepared by the reaction of b-sitosterol and succinic anhydride in toluene with a catalytic amount of DMAP. The chlorination of the resulting acid compound 1 with SOCl2 and then direct amination with appropriate amines afforded N-substituted succinamic acid b-sitosteryl ester derivatives 2. Compounds 2 were also synthesized in 76—92% yields by the reaction of 1 with methyl chloroformate, followed by amination of the activated intermediate. Interestingly, compound 2a (DANA87) was also easily obtained in one step by the direct addition of b-sitosterol to dicyclohexylcarbodiimide (DCC) in 80% yield. It was considered that compound DANA87 was prepared by slow thermal degradation of the May 2004 Notes Chem. Pharm. Bull. 52(5) 597—601 (2004) 597

24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist.

Effects of Stigmasterol and Β-Sitosterol on Nonalcoholic Fatty Liver Disease in a Mouse Model: A Lipidomic Analysis.

Bioactive steroids from the brown alga Sargassum carpophyllum

Phytosterols and Their Derivatives: Potential Health-Promoting Uses Against Lipid Metabolism and Associated Diseases, Mechanism, and Safety Issues.

Discovery of Anti-Hypercholesterolemia Agents Targeting LXRα from Marine Microorganism-Derived Natural Products

The edible seaweed Laminaria japonica contains cholesterol analogues that inhibit lipid peroxidation and cyclooxygenase enzymes

PL-S2, a homogeneous polysaccharide from Radix Puerariae lobatae, attenuates hyperlipidemia via farnesoid X receptor (FXR) pathway-modulated bile acid metabolism

Sulfated Oxysterol, 25hc3s, is A Potent Regulator of Lipid Metabolism in Human Hepatocytes

Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1

Preliminary Structure-Activity Relationship on Theonellasterol, a New Chemotype of FXR Antagonist, from the Marine Sponge Theonella swinhoei

A Novel Steroid for Sargassum Carpophyllum

Hypolipidemic Activity and Mechanism of Action of Sargassum fusiforme Polysaccharides

Catalyst-free synthesis of phytosterol diacid monoesters and their competitive effect on the solubilization of cholesterol in model bile mixed micelles

Enhancement of Galloylation Efficacy of Stigmasterol and Β-Sitosterol Followed by Evaluation of Cholesterol-Reducing Activity.

A New Cytotoxic Cholesterol Sulfate From Marine Sponge Halichondria Rugosa

Novel triterpenoids from <i>Alisma plantago-aquatica</i> with influence on LDL uptake in HepG2 cells by inhibiting PCSK9

Effect of a New b-Sitosterol Analogue on Plasma Lipid Concentrations in Rats 1 )

The Hypocholesterolemic Potential of the Edible Algae Fucus vesiculosus: Proteomic and Quantitative PCR Analysis

Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: from Discovery to Clinical Usage

Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells

Oxysterol Sulfation by Cytosolic Sulfotransferase Suppresses Liver X Receptor/sterol Regulatory Element Binding Protein-1C Signaling Pathway and Reduces Serum and Hepatic Lipids in Mouse Models of Nonalcoholic Fatty Liver Disease.